We have 87 products in: Biochemicals >> Research Area >> Hypertension >> Signaling >> Signal transduction
Signal transduction beginning with A - P |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Second messenger. PKA activator. Purity: > 98% | | ||
| JAK2/3 inhibitor Purity: > 99% | | ||
| Highly selective CXCR4 antagonist Purity: > 99% | | ||
| NOS inhibitor Purity: > 98% | | ||
| Protein synthesis inhibitor Purity: > 98% | | ||
| Ca2+ release modulator Purity: > 98% | | ||
| Precursor to nitric oxide synthesis Purity: > 99% | | ||
| Novel, potent and selective JAK2 inhibitor Purity: > 95% | | ||
| Apoptotic anti-cancer, anti-inflammatory and anti-oxidant curcuminoid Purity: > 98% | | ||
| Specific NF-κB inhibitor Purity: > 98% | | ||
| Anti-inflammatory and anti-proliferative agent Purity: > 99% | | ||
| MNK inhibitor Purity: > 98% | | ||
| Antioxidant with a variety of biological effects Purity: > 99% | | ||
| 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP) | Cell permeable cAMP analogue, protein kinase modulator Purity: > 98% | | |
| Antioxidant flavonoid; potent anti-inflammatory effects Purity: > 99% | | ||
| Akt peptide substrate Purity: > 98% | | ||
| Akt peptide substrate, biotinylated Purity: > 98% | | ||
| STAT3 inhibitor with diverse biological activities Purity: > 99% | | ||
| Hh signaling inhibitor Purity: > 97% | | ||
| Potent anti-oxidant flavonoid Purity: > 98% | | ||
| Selective mineralocorticoid antagonist Purity: > 99% | | ||
| Adenylyl cyclase activator Purity: > 98% | | ||
| Downstream Hh signaling inhibitor Purity: > 99% | | ||
| Selective GLI1 and 2 inhibitor Purity: > 98% | | ||
| Potent, non-selective PI3K inhibitor Purity: > 95% | | ||
| Kinase inhibitor Purity: > 98% | | ||
| Anti-inflammatory and chemotherapeutic agent Purity: > 98% | | ||
| Endogenous indole derivative; mitochondrial metabolism modifier. Purity: > 99% | | ||
| Cell-permeable STAT5 inhibitor Purity: > 98% | | ||
| Non selective β-adrenoceptor agonist Purity: > 99% | | ||
| Smoothened inhibitor Purity: > 98% | | ||
| Nitric oxide synthase inhibitor Purity: > 99% | | ||
| Antioxidant, anti-inflammatory, anti-cancer flavonoid Purity: > 99% | | ||
| PI3-kinase inhibitor Purity: > 99% | | ||
| Selective iNOS inhibitor; peroxynitrite scavenger | | ||
| Potent antitumor and antiangiogenic agent Purity: > 98% | | ||
| Antibiotic. Demonstrates multiple effects. Purity: > 99% | | ||
| Selective JAK2 inhibitor Purity: > 95% | | ||
| NOS inhibitor Purity: > 99% | | ||
| Vasodilator. Active metabolite of molsidomine. Purity: > 98% | | ||
| Novel, high affinity smoothened (Smo) antagonist Purity: > 99% | | ||
| Potent anti-neoplastic, anti-oxidant and anti-inflammatory agent Purity: > 97% | | ||
| NOS inhibitor Purity: > 98% | | ||
| NOS inhibitor Purity: > 98% | | ||
| NO donor | | ||
| Water-soluble analogue of forskolin ( Purity: > 98% | | ||
| Selective JAK2 inhibitor Purity: > 95% | | ||
| Potent PDE inhibitor Purity: > 98% | | ||
| Potent MEK 1 and 2 inhibitor Purity: > 99% | | ||
| MEK1 inhibitor Purity: > 99% | | ||
| Selective NF-κB inhibitor; antioxidant Purity: > 98% | | ||
| Phosphodiesterase inhibitor. Cytokine inhibitor. Purity: > 99% | | ||
| Potent, selective casein kinase 1ε (CK1ε) and CK1δ inhibitor Purity: > 99% | | ||
| Novel, potent, ATP-competitive PI3K, mTOR and DNA-PK inhibitor Purity: > 95% | | ||
| Potent, selective mutant B-RafV600E and c-Raf-1Y340D/Y341D inhibitor Purity: > 95% | | ||
| Potent and selective mTOR inhibitor Purity: > 98% | | ||
| Smoothened receptor agonist Purity: > 98% | |